Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAF(V600E) mutant melanoma cells.

Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAF(V600E) mutant melanoma cells.
复制标题

DOI:
10.1021/pr5002516
复制
发表时间:
2014-11-07
影响因子:
4.4
通讯作者:
Ahmad, Nihal
Ahmad, Nihal
中科院分区:
生物学2区
文献类型:
--
作者:
Cholewa, Brian D.;Pellitteri-Hahn, Molly C.;Scarlett, Cameron O.;Ahmad, Nihal

文献摘要

参考文献

被引文献

相似文献

Polo-like kinase 1 (Plk1) is a serine/threonine kinase that plays a key role during the cell cycle by regulating mitotic entry, progression, and exit. Plk1 is overexpressed in a variety of human cancers and is essential to sustained oncogenic proliferation, thus making Plk1 an attractive therapeutic target. However, the clinical efficacy of Plk1 inhibition has not emulated the preclinical success, stressing an urgent need for a better understanding of Plk1 signaling. This study addresses that need by utilizing a quantitative proteomics strategy to compare the proteome of BRAFV600E mutant melanoma cells following treatment with the Plk1-specific inhibitor BI 6727. Employing label-free nano-LC–MS/MS technology on a Q-exactive followed by SIEVE processing, we identified more than 20 proteins of interest, many of which have not been previously associated with Plk1 signaling. Here we report the down-regulation of multiple metabolic proteins with an associated decrease in cellular metabolism, as assessed by lactate and NAD levels. Furthermore, we have also identified the down-regulation of multiple proteasomal subunits, resulting in a significant decrease in 20S proteasome activity. Additionally, we have identified a novel association between Plk1 and p53 through heterogeneous ribonucleoprotein C1/C2 (hnRNPC), thus providing valuable insight into Plk1’s role in cancer cell survival.
DOI: 10.1074/jbc.c111.269050
发表时间: 2011-10-14
影响因子: 4.8
作者:
Liu, X. Shawn;Song, Bing;Liu, Xiaoqi
通讯作者: Liu, Xiaoqi
DOI: 10.4161/cc.9.20.13532
发表时间: 2010-10-15
期刊: CELL CYCLE
影响因子: 4.3
作者:
McKenzie, Lynsey;King, Sharon;Meek, David W.
通讯作者: Meek, David W.
DOI: 10.1016/j.jprot.2009.03.004
发表时间: 2009-07-21
影响因子: 3.3
作者:
Guillaume, Elisabeth;Berger, Bernard;Kussmann, Martin
通讯作者: Kussmann, Martin
DOI: 10.1083/jcb.135.6.1701
发表时间: 1996-12
影响因子: 7.8
作者:
Lane, HA;Nigg, EA
通讯作者: Nigg, EA
DOI: 10.1371/journal.pone.0033752
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Gámez-Pozo A;Sánchez-Navarro I;Calvo E;Agulló-Ortuño MT;López-Vacas R;Díaz E;Camafeita E;Nistal M;Madero R;Espinosa E;López JA;Fresno Vara JÁ
通讯作者: Fresno Vara JÁ